EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 166 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $563,000 | -23.4% | 12,100 | -30.1% | 0.00% | -20.0% |
| Q3 2020 | $735,000 | -55.5% | 17,300 | -49.7% | 0.01% | -61.5% |
| Q2 2020 | $1,651,000 | +7.1% | 34,400 | +2.7% | 0.01% | +62.5% |
| Q1 2020 | $1,541,000 | -25.2% | 33,500 | -2.3% | 0.01% | -50.0% |
| Q4 2019 | $2,061,000 | +7.2% | 34,300 | +0.9% | 0.02% | 0.0% |
| Q3 2019 | $1,923,000 | -12.6% | 34,000 | -13.9% | 0.02% | -15.8% |
| Q2 2019 | $2,199,000 | -22.2% | 39,500 | -29.5% | 0.02% | -26.9% |
| Q1 2019 | $2,827,000 | +34.2% | 56,000 | +7.1% | 0.03% | +36.8% |
| Q4 2018 | $2,107,000 | -31.9% | 52,300 | +17.3% | 0.02% | -17.4% |
| Q3 2018 | $3,092,000 | – | 44,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |